Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

No spatial working memory deficit in beta-amyloid-exposed rats. A longitudinal study.

Eva von Linstow Roloff1, Bettina Platt, Gernot Riedel

  • 1Department of Biomedical Sciences, Institute of Medical Sciences, University of Aberdeen, Foresterhill, Aberdeen AB25 2ZD, Scotland, UK.

Progress in Neuro-Psychopharmacology & Biological Psychiatry
|October 9, 2002
PubMed
Summary

Long-term intrahippocampal beta-amyloid protein 1-40 (beta A1-40) administration in rats did not impair spatial working memory alone but exacerbated scopolamine-induced amnesia, suggesting altered cholinergic transmission.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reproducible social phenotyping of 5xFAD mice in the Agora maze (Sociobox).

Behavioural brain research·2026
Same author

Announcement of special issue: 'Behavioural pharmacology of ketamine and psychedelic drugs'.

Behavioural pharmacology·2026
Same author

Timing matters: early administration of a high-affinity antibody targeting the tau repeat domain prevents aggregation in a mouse tauopathy model.

Alzheimer's research & therapy·2026
Same author

The Icelandic Mutation in the Murine APP Gene, mAPP<sup>A673T</sup>, on Amyloid-β Plaque Burden in the 5×FAD Alzheimer Model.

Journal of integrative neuroscience·2026
Same author

Effect of the Icelandic Mutation APP<sup>A673T</sup> in the Murine APP Gene on Phenotype of Line 66 Tau Mice.

Biomolecules·2026
Same author

Effects of hydromethylthionine mesylate and rivastigmine in a pharmacological mouse model of Alzheimer's disease.

Behavioural pharmacology·2025

Area of Science:

  • Neuroscience
  • Neurobiology
  • Pharmacology

Background:

  • Alzheimer's disease is characterized by amyloid-beta (Aβ) plaques.
  • Aβ's role in cognitive deficits, particularly spatial working memory, is under investigation.
  • Long-term effects of Aβ administration on memory require further elucidation.

Purpose of the Study:

  • To investigate the long-term effects of intraventricular and intrahippocampal beta-amyloid protein 1-40 (beta A1-40) administration on spatial working memory in rats.
  • To assess the impact of beta A1-40 in combination with aluminum exposure and its potential reversal by nefiracetam.
  • To determine if beta A1-40 administration sensitizes rats to the memory-impairing effects of scopolamine.

Main Methods:

  • Two experiments using rats with intraventricular or intrahippocampal minipumps delivering beta A1-40 or control peptides.

Related Experiment Videos

  • Spatial working memory assessed using a delayed matching-to-position (DMTP) procedure in an open-field water maze.
  • Experiment 1: Rats exposed to aluminum sulfate orally, then received beta A1-40 icv, with or without nefiracetam.
  • Experiment 2: Rats received intrahippocampal beta A1-40 or a control peptide, followed by testing with or without scopolamine injection.

    • Main Results:

    • Long-term oral aluminum exposure alone did not affect spatial working memory.
    • Intracerebroventricular beta A1-40 administration caused transient increases in latency, with no lasting memory impairment.
    • Beta A1-40 administration in aluminum-exposed rats led to a progressive working memory decline, reversed by nefiracetam.
    • Intrahippocampal beta A1-40 administration did not impair spatial working memory on its own.
    • Rats with intrahippocampal beta A1-40 became significantly more susceptible to scopolamine-induced amnesia.

    Conclusions:

    • Long-term intrahippocampal beta A1-40 administration may subtly alter cholinergic transmission without causing overt spatial working memory deficits in well-trained rats.
    • Combined exposure to beta A1-40 and aluminum exacerbates working memory impairment, which can be ameliorated by nefiracetam.
    • Beta A1-40 appears to prime the brain for memory impairment by cholinergic antagonists, highlighting a potential mechanism in Alzheimer's disease pathology.